The two day international conference on Sustainable Bio fuels was held in New Delhi. It was jointly being organized by Section of Biotechnology and Bio future platform.
It aimed to provide common system to Government policy makers, industry, investors and research community to exchange experiences and challenges related to development and scaling of advance biofuels. It also focused on concerns of private industries to speed up large scale production of sustainable biofuels Mission Innovation (MI) is a global initiative of 22 countries and the European Union to dramatically accelerate global clean energy advancement. As part of the initiative, participating countries have committed to double Clean Energy Research and Development ventures over five years.
The Sustainable Biofuel is one of the Seven Mission Innovation Challenges and India Co-leads this along with other countries Brazil, Canada and China. Sustainable Bio fuel development is a key challenge as well as an opportunity for Governments, researchers, investors and industry to work together. Lasting biofuels have seen rapid R&D and performance breakthroughs, however still there are challenges as most exciting bio fuels still remain at an early-commercial stage of development.
A two- day International Conference on Sustainable Biofuels is jointly organization by Department of Biotechnology, Govt. of India on behalf of Objective Development and Bio future Platform at the Stein Auditorium, India Habitat Centre, New Delhi. The event will bring jointly experts from Biofuels sector to take stock of current knowledge, share information and best practices, and build consensus on the actions most needed to move forward. Mature Government Officers, Techie Experts, Academicians, Researchers and Representatives from various Countries, Industry and Investors will participate in the event.
Union Minister for Science and technology, Earth Sciences and Environment Forest & Environment Change, Dr. Harsh Vardhan, will be Key Guest and will inaugurate and address the International Meeting followed by Exhibition on February 26th, 2018. Shri V.K. Saraswat, Member NITI Aayog will deliver the keynote address, Prof. Ashutosh Sharma, Secretary Division of Biotechnology & Section of Technology & Technology would deliver the address to the gathering. Ms Sarah Web, Head Mission Advancement Secretariat UK would present her perspectives from Mission Innovation Objectives while Ambassador Antonio Marcondes, Ministry of Foreign Affairs, Brazil would talk about Bio future Platform and expectation from member Countries.
A plenary talk on “Advance Biofuels-Pathways to decarbonize transport fuels” will be given by Prof Jack Saddler, UBC Canada. Representative from Members countries of Objective Creativity and Bio future System and from International Energy Agency (IEA) will be actively participating in the event.
On this occasion, more than 300 participants with representatives from 18 countries will be attending it. This event goals to provide a common platform to Government plan makers, industry, traders and research community to exchange experiences and difficulties related to development and scaling of advance biofuels. Besides this the conference will focus on concerns of the private areas to increase large scale creation of lasting biofuels.
The Inaugural session will be accompanied by a core plenary talk on “Sustainable Biofuels”. This would be followed by sessions focusing on National Perspectives, Collaboration Opportunities, Technology Development and Need for Invention, Global Status of Biofuel Technology Scale-up opportunities, Advanced Bio-fuels and Policy Support for Commercialization. The discussion on these domains shall seek to a definite understanding of the development in bio-economy made by taking part countries, increase awareness of policy makers about the problems faced by the industry-investor for commercial scale up of advanced biofuels. The need for collaboration-cooperation to speed up commercialization and concentrate on latest R&D in advanced biofuels will be the expected final results of this International event.
The conference will seek to an obvious knowledge of the development in bio-economy created by participating countries, increase knowing of policy makers about the challenges faced by the industry-investor for commercial scale up of advanced Biofuels. A “New Delhi Declaration on Sustainable Biofuels” will be endorsed during this International Conference which has been prepared in consultation with the Mission Technology Member countries, and Biofuture Platform group. The Meeting along with the Exhibition is a community forum to showcase Best Practices, Innovative Technology. The Conference will be of two days’ duration which includes sessions on selected designs and sub-themes, exhibition, ethnic function and other related activities.
Union Minister for Research and technology Dr. Harsh Vardhan will inaugurate the Meeting.
A Biofuel is a fuel that is produced through contemporary biological processes, such as agriculture and anaerobic digestion, rather than a fuel produced by geological procedures such as those involved in the formation of fossil fuels, such as coal and petroleum, from prehistoric biological matter.
Biofuels can be derived directly from plants, or indirectly from agricultural, commercial, domestic, and/or industrial wastes. Renewable biofuels generally involve modern carbon fixation, such as those that occur in vegetation or microalgae through the process of photosynthesis.
Other renewable biofuels are made through the use or conversion of biomass (referring to recently living organisms, most often referring to plant life or plant-derived materials). This biomass can be converted to convenient energy-containing substances in three different ways: thermal conversion, chemical transformation, and biochemical conversion. This biomass transformation can result in fuel in solid, liquid, or gas form. This new biomass can also be used directly for Biofuel.
The Union Ministry of Health insurance and Family Welfare launched ‘Viral Insert testing’ for everyone Coping with HIV/Helps (PLHIV). The viral fill test actions amount of HIV in bloodstream amount of copies of HIV RNA in millilitre of blood.The authorities launched a system to provide cost free viral load tests, at least one time a complete season, for 1.2 million folks who are living with HIV/AIDS (PLHIV) and are on treatment.
The viral load can be used to monitor the effectiveness of Antiretroviral Therapy (ART) as time passes. It measures the quantity of HIV genetic materials (RNA) in the blood and reports just how many copies of the virus can be found.
Health minister J.P. Nadda, while introducing the initiative in New Delhi, said that with the effort the country wide federal government will monitor the potency of treatment of patients on lifelong Artwork treatment.
In 2017, India revised the creative artwork treatment protocols to initiate all PLHIV on ART. The ‘treat all’ effort was began to ensure that treatment is began early and the virus transmitting is curtailed both at the average person and the city level.
Based on the union health ministry, about 1.2 million PLHIV are availing the advantage of free treatment from more than 530 Artwork centres.
India has the third largest population of people with HIV after South Nigeria and Africa, according to UNAIDS. N July 2017 exposed that in India the survey released, only 49% of patients were on Antiretroviral therapy (ART) in 2016. India acquired 2.1 million people living with HIV at the final end of 2016 and 36.7 million globally, based on the report.
Closing the stigma for the PLHIV was necessary to enable them to gain access to health services, the minister said. “To facilitate decrease in discrimination and stigma, the long pending HIV/Helps Action has been exceeded, which really is a historical step. Very few countries globally have such a statutory law to protect rights of individuals infected with HIV,” Health minister J.P. Nadda stated.
The Minister further added that the regimen viral weight screening shall optimize the utilization of first-line regimens, thus preventing drug level of resistance and ensuring the longevity of people living with HIV.
According to WHO recommendations, India, in 2017, revised the anti-retroviral treatment protocols to start all PLHIV to Artwork. Currently about 12 lakh PLHIV are going through treatment in more than 530 ART centres.
Regimen viral fill tests shall optimize the utilization of first line regimens, thus preventing medication resistance and ensuring the longevity of individuals coping with HIV. Viral Insert assessment will empower medical officers at Artwork to detect failing on first series treatment early and for that reason save PLHIV from developing resistance to drugs.
“The routine viral insert testing shall optimize the use of first collection regimens, thus preventing drug resistance and ensuring the longevity of individuals coping with HIV. Viral load examining will empower medical officers at ART to detect failure on first range treatment early and therefore save PLHIV from developing level of resistance to drugs. It can help in building up also ‘Mission Sampark’ in tracking LFU (reduction to check out up) PLHIV and also to be brought under Artwork services,” said Nadda.
Viral load, known as viral burden also, viral titre or viral titer, is a numerical expression of the amount of virus in confirmed volume. It really is indicated as viral particles often, or infectious particles per mL with respect to the kind of assay. An increased viral burden, titre, or viral insert correlates with the severe nature of a dynamic viral infection often. The amount of pathogen / mL can be determined by estimating the live amount of Trojan within an included body fluid.
For instance, it could be given in RNA copies per millilitre of bloodstream plasma. Tracking viral weight is used to monitor therapy during chronic viral attacks, and in immuno compromised patients such as those dealing with bone marrow or solid organ transplantation. Presently, routine examining is designed for HIV-1, cytomegalovirus, hepatitis B virus, and hepatitis C computer virus.